Furthermore, the nuclear receptor superfamily of ligand-activated transcription factors includes the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonists which can treat type 2 diabetes and obesity-related insulin resistance [3]. The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.